Fat tissue, aging, and cellular senescence
Tóm tắt
Fat tissue, frequently the largest organ in humans, is at the nexus of mechanisms involved in longevity and age‐related metabolic dysfunction. Fat distribution and function change dramatically throughout life. Obesity is associated with accelerated onset of diseases common in old age, while fat ablation and certain mutations affecting fat increase life span. Fat cells turn over throughout the life span. Fat cell progenitors, preadipocytes, are abundant, closely related to macrophages, and dysdifferentiate in old age, switching into a pro‐inflammatory, tissue‐remodeling, senescent‐like state. Other mesenchymal progenitors also can acquire a pro‐inflammatory, adipocyte‐like phenotype with aging. We propose a hypothetical model in which cellular stress and preadipocyte overutilization with aging induce cellular senescence, leading to impaired adipogenesis, failure to sequester lipotoxic fatty acids, inflammatory cytokine and chemokine generation, and innate and adaptive immune response activation. These pro‐inflammatory processes may amplify each other and have systemic consequences. This model is consistent with recent concepts about cellular senescence as a stress‐responsive, adaptive phenotype that develops through multiple stages, including major metabolic and secretory readjustments, which can spread from cell to cell and can occur at any point during life. Senescence could be an alternative cell fate that develops in response to injury or metabolic dysfunction and might occur in nondividing as well as dividing cells. Consistent with this, a senescent‐like state can develop in preadipocytes and fat cells from young obese individuals. Senescent, pro‐inflammatory cells in fat could have profound clinical consequences because of the large size of the fat organ and its central metabolic role.
Từ khóa
Tài liệu tham khảo
Berryman DE, 2009, Two‐year body composition analyses of long‐lived GHR null mice, J. Gerontol. A Biol. Sci. Med. Sci., 65, 31
Bjorntorp P, 1990, Obesity and adipose tissue distribution as risk factors for the development of disease. A review, Infusionstherapie, 17, 24
Boney CM, 2001, Src family tyrosine kinases participate in insulin‐like growth factor I mitogenic signaling in 3T3‐L1 cells, Cell Growth Differ., 12, 379
Campisi J, 2000, Cancer, aging and cellular senescence, In Vivo, 14, 183
Denke MA, 1993, Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men, Arch. Intern. Med., 153, 1093, 10.1001/archinte.1993.00410090045006
Fried S, 1987, Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients, Int. J. Obes., 11, 129
Kirkland JL, 1997, Decreasing preadipocyte differentiation capacity with aging is associated with blunted expression of the transcription factor, CCAAT enhancer binding protein a, Obes. Res., 5, 22S
Kirkland JL, 2003, Adipose tissue as an endocrine organ: regional differences in adipocyte endocrine function, Prog. Obes. Res., 9, 87
Kotani K, 1994, Sexual dimorphism of age‐related changes in whole‐body fat distribution in the obese, Int. J. Obes. Relat. Metab. Disord., 18, 207
Shillabeer G, 1990, Paradoxically slow preadipocyte replication and differentiation in corpulent rats, Am. J. Physiol., 258, E368
Tchkonia T, 2009, Cellular senescence and inflammation in obesity, Obesity, 17, S57
Turkenkopf IJ, 1988, Regional and genotypic differences in stromal‐vascular cells from obese and lean Zucker rats, Int. J. Obes. Relat. Metab. Disord., 12, 515
Yki‐Jarvinen H, 1986, Insulin binding and action in adipocytes in vitro in relation to insulin action in vivo in young and middle‐aged subjects, Acta Endocrinol., 113, 88